Trials / Conditions / T-ALL/Lymphoma
T-ALL/Lymphoma
3 registered clinical trials studyying T-ALL/Lymphoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies NCT06909474 | Chongqing Precision Biotech Co., Ltd | Phase 1 |
| Recruiting | The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors NCT06911710 | Tianjin Medical University General Hospital | Phase 1 / Phase 2 |
| Unknown | CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ Lymphoma NCT05212584 | iCell Gene Therapeutics | Phase 1 |